Announcements Trials
Browse Landscape

Phase

Phase 2 1Phase 1 1

Status

Unknown 2Completed 2Recruiting 1

Sponsor Class

INDUSTRY 2

Study Type

Interventional 2

Sponsor

Cancer Type

Other hematologic neoplasm 2Myeloid 1

Conditions

Leukemia, Myeloid, Chronic-Phase 2Leukemia, Myelogenous, Chronic, BCR-ABL Positive 2

Interventions

Cyclophosphamide 59fludarabine phosphate 56Peripheral Blood Stem Cell Transplantation 55Busulfan 42Cyclosporine 39Mycophenolic Acid 35Antilymphocyte Serum 34Filgrastim 32Tacrolimus 31Radiotherapy 31Imatinib Mesylate 28Whole-Body Irradiation 25Methotrexate 24Methylprednisolone 23Cord Blood Stem Cell Transplantation 18sargramostim 16Etoposide 16Dasatinib 16Interferon-alpha 15Cytarabine 15Melphalan 14nilotinib 11Thiotepa 9Therapeutics 9Cyclosporins 9Flow Cytometry 8Psychiatric Rehabilitation 7Polymerase Chain Reaction 6thymoglobulin 5merphos 5

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Completed × Leukemia, Myeloid, Chronic-Phase × olverembatinib × Clear all
NCT04126681 2025-03-03

A Pivotal Study of HQP1351 in Patients With Chronic Myeloid Leukemia in Chronic Phase

Ascentage Pharma Group Inc.

Phase 2 Completed
144 enrolled
MyeloidOther hematologic neoplasm

Leukemia, Myelogenous, Chronic, BCR-ABL Positive, Leukemia, Myeloid, Chronic-Phase

NCT03882281 2020-01-22

CML

Ascentage Pharma Group Inc.

Phase 1 Completed
12 enrolled
Other hematologic neoplasm

Leukemia, Myeloid, Chronic-Phase

Data powered by HemOnc (CC BY 4.0) Colophon âš¡